August 11, 2026
MindImmune CEO Isaac Stoner on treating Alzheimer's as an immune disease, de-risking trials with early biomarkers, and building peer networks.
May 12, 2026
Outgoing CEO Chris O'Brien & new host Melissa Allesley discuss AI's impact on drug development, biotech funding, and leadership lessons learned.
December 16, 2025
Ora Clinical founder Dr. Mark Abelson on pioneering the CRO industry, the evolution of clinical trials, and viewing protocol development as an art.
